Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Deficit)

v3.24.2.u1
Condensed Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Shares
Class A Common Shares
Common Shares
Common Shares Issuable
Additional Paid-in Capital
Accumulated Deficit
Total
Balances at Dec. 31, 2022   $ 1 $ 1,885 $ 241,117 $ (262,486) $ (19,483)
Balances (in Shares) at Dec. 31, 2022 700,000 9,586,683        
Issuance of common shares, net of offering costs - Registered direct offering   $ 1   21,113   21,114
Issuance of common shares, net of offering costs - Registered direct offering (in Shares)   4,530,000        
Issuance of common shares - Founders Agreement     (1,885) 2,443   558
Issuance of common shares - Founders Agreement (in Shares)   528,527        
Stock-based compensation expense       1,536   1,536
Stock-based compensation expense (in Shares)   1,101,098        
Exercise of pre-funded and common stock warrants (in shares)   1,492,085        
Net loss         (26,995) (26,995)
Balances at Jun. 30, 2023   $ 2   266,209 (289,481) (23,270)
Balances (in Shares) at Jun. 30, 2023 700,000 17,238,393        
Balances at Dec. 31, 2022   $ 1 1,885 241,117 (262,486) (19,483)
Balances (in Shares) at Dec. 31, 2022 700,000 9,586,683        
Balances at Dec. 31, 2023   $ 3 3,419 297,864 (314,333) (13,047)
Balances (in Shares) at Dec. 31, 2023 700,000 27,042,035        
Balances at Mar. 31, 2023   $ 1   250,780 (272,960) (22,179)
Balances (in Shares) at Mar. 31, 2023 700,000 13,201,070        
Issuance of common shares, net of offering costs - Registered direct offering   $ 1   14,460   14,461
Issuance of common shares, net of offering costs - Registered direct offering (in Shares)   3,350,000        
Issuance of common shares - Founders Agreement       402   402
Issuance of common shares - Founders Agreement (in Shares)   123,906        
Stock-based compensation expense       567   567
Stock-based compensation expense (in Shares)   104,148        
Exercise of pre-funded and common stock warrants (in shares)   459,269        
Net loss         (16,521) (16,521)
Balances at Jun. 30, 2023   $ 2   266,209 (289,481) (23,270)
Balances (in Shares) at Jun. 30, 2023 700,000 17,238,393        
Balances at Dec. 31, 2023   $ 3 3,419 297,864 (314,333) (13,047)
Balances (in Shares) at Dec. 31, 2023 700,000 27,042,035        
Issuance of common shares, net of offering costs - Registered direct offering   $ 1   12,636   12,637
Issuance of common shares, net of offering costs - Registered direct offering (in Shares)   1,275,000        
Issuance of common shares - Founders Agreement     (3,419) 3,815   396
Issuance of common shares - Founders Agreement (in Shares)   1,686,820        
Stock-based compensation expense       1,880   1,880
Stock-based compensation expense (in Shares)   5,322,412        
Exercise of pre-funded and common stock warrants (in shares)   6,305,233        
Net loss         (17,615) (17,615)
Balances at Jun. 30, 2024   $ 4   316,195 (331,948) (15,749)
Balances (in Shares) at Jun. 30, 2024 700,000 41,631,500        
Balances at Mar. 31, 2024   $ 4 3,419 311,605 (325,278) (10,250)
Balances (in Shares) at Mar. 31, 2024 700,000 34,986,279        
Issuance of common shares - Founders Agreement     $ (3,419) 3,419    
Issuance of common shares - Founders Agreement (in Shares)   1,492,915        
Stock-based compensation expense       1,171   1,171
Stock-based compensation expense (in Shares)   2,642,306        
Exercise of pre-funded and common stock warrants (in shares)   2,510,000        
Net loss         (6,670) (6,670)
Balances at Jun. 30, 2024   $ 4   $ 316,195 $ (331,948) $ (15,749)
Balances (in Shares) at Jun. 30, 2024 700,000 41,631,500